Skip to main content
Screener/Healthcare/Biotechnology

FHTX — Foghorn Therapeutics Inc.

NASDAQ
$6.13+0.56 (+10.14%)
Micro CapUnder $10Healthcare
$3.27
$6.95
$5.51
$6.17
EPS (TTM)$-1.17
P/E Ratio-4.38
Dividend Yield—
Market Cap$297.7M
Volume219K
Prev Close$5.57
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$3.3M-$19.9M$-0.290.0%-608.4%
Q4 '25$9.2M-$21.7M$-0.3591.3%-234.3%
Q3 '25$8.2M-$15.8M$-0.25-145.3%-194.4%
Q2 '25$7.6M-$17.9M$-0.2888.1%-237.3%
Q1 '25$6.0M-$18.8M$-0.30100.0%-316.4%
Q4 '24$2.9M-$19.5M$-0.31100.0%-682.9%
Q3 '24$7.8M-$19.1M$-0.31100.0%-244.9%
Q2 '24$6.9M-$23.0M$-0.45100.0%-333.6%
Get Your Daily Market Recap